Propeller Bio
Propeller Bio is a privately held biologic therapeutic company based in Redwood City, California. As of the available data, the company operates in a pre-launch state, with its website showing only a Coming Soon page and no disclosed products, pipeline, or team.
- Company typePrivate
- Founded-
- HeadquartersRedwood City, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Propeller Bio does
Propeller Bio is described as a biologic therapeutic company headquartered in Redwood City, California, United States. The company is privately held and, based on available source material, appears to be in a pre-launch or early operational stage: its website (propeller-bio.com) currently displays only a "Coming Soon" landing page with a 2026 copyright notice and no substantive product, scientific, or team disclosures. No core products, therapeutic pipeline, underlying technology platform, or modality focus (e.g., antibodies, cell therapies, gene therapies) are documented in the public source material reviewed.
The business model, go-to-market motion, customer segments, pricing, and revenue mechanics are not disclosed. No select customers, partnerships, alliances, regulatory milestones, management team, funding rounds, headcount, patents, trademarks, awards, or certifications are present in the available data. The legal name is recorded as "Propeller BIO" and the company operates under the trade name "Propeller Bio," but there is no information on ownership structure, founders, investors, or parent/subsidiary relationships. Operating geographies are likewise unspecified.
The data profile is consistent with either a stealth-mode formation, a newly incorporated shell awaiting operational build-out, or a pre-launch entity that has not yet publicly disclosed its scientific platform or pipeline. Any investment-relevant inference about scientific differentiation, addressable market, or capital readiness cannot be supported by the current source material and represents a material data gap.
Propeller Bio firmographics
Firmographics- Name
- Propeller Bio
- Legal name
- Propeller BIO
- Website
- https://propeller-bio.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Propeller Bio is a privately held biologic therapeutic company based in Redwood City, California. As of the available data, the company operates in a pre-launch state, with its website showing only a Coming Soon page and no disclosed products, pipeline, or team.
- Ownership category
- akta.pro rank
Propeller Bio industry classification
Industry- Product category
- Biologic Therapeutics
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where Propeller Bio is headquartered
LocationHeadquarters
- HQ city
- Redwood City
- HQ country
- United States
- HQ region
- North America
Markets served
Propeller Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Propeller Bio product offering
Product offeringCore offering
Propeller Bio is a biologic therapeutic company based in Redwood City, United States. The company is in a pre-launch stage, as its website currently displays a "Coming Soon" landing page with no detailed product, pipeline, or service information disclosed. Based on its self-description as a biologic therapeutic company, it appears intended to develop biologic-based therapeutic products.
Differentiator
Problem solved
Functional benefit
Companies that use Propeller Bio
Customer profileIdeal customer profiles1 record
Propeller Bio technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Propeller Bio partnerships and signals
Strategic signalRecent moves1 record
Propeller Bio competitors and assessment
Company assessmentDirect peers
- Crinetics Pharmaceuticals: Bay Area-based clinical-stage biologic therapeutics company developing peptide and small-molecule-based drugs for endocrine diseases. Comparable to Propeller Bio as a California-headquartered therapeutics developer; however Crinetics is significantly more advanced and publicly traded.
- CytomX Therapeutics: Clinical-stage oncology biologics company developing Probody antibody therapeutics. Comparable to Propeller Bio as a biologic therapeutics developer with a platform-based approach to differentiated antibody constructs.
- Surrozen: Clinical-stage biologics company developing antibody-based therapeutics that target the Wnt pathway. Comparable as a Bay Area-based biologic therapeutic developer at a similar stage of platform development.
- Werewolf Therapeutics: Clinical-stage biopharmaceutical company developing conditionally activated biologic therapeutics for oncology. Comparable as a platform-based biologic therapeutics developer targeting tissue-specific modulation.
- Adagene: Clinical-stage biopharmaceutical company using a dynamic precision biology platform to develop antibody-based therapeutics. Comparable as a platform-driven biologic therapeutics developer.
- AbCellera Biologics: Vancouver-based antibody discovery platform company that partners with pharma to develop biologic therapeutics. Comparable to Propeller Bio as a biologic discovery and therapeutic development platform.
- Generate Biomedicines: Pre-clinical biotech using generative biology to create novel protein therapeutics. Comparable as a platform-based biologic therapeutics developer, with a similar pre-launch / early platform status to Propeller Bio.
- Atreca: Clinical-stage biotech leveraging immune repertoire sequencing to discover and develop biologic therapeutics. Comparable as a Bay Area-headquartered platform-based biologic therapeutics developer.
Broad incumbents
- BioMarin Pharmaceutical: Major Bay Area-based biotech specializing in biologic therapeutics for rare diseases. Comparable as a Redwood City-area (San Rafael) biologic therapeutics company; serves as a broad incumbent benchmark for the regional competitive and talent landscape.
- Ginkgo Bioworks: Large synthetic biology platform company that engineers organisms for therapeutic and industrial applications. Comparable as a broad incumbent in biologic platform development, with overlap in synthetic biology approaches relevant to biologics.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights3 records
Customer concentration
Propeller Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Propeller Bio leadership team
Management profileNumber of profiles
Propeller Bio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Propeller Bio M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Propeller Bio
What does Propeller Bio do?
Propeller Bio is a biologic therapeutic company based in Redwood City, United States. The company is in a pre-launch stage, as its website currently displays a "Coming Soon" landing page with no detailed product, pipeline, or service information disclosed. Based on its self-description as a biologic therapeutic company, it appears intended to develop biologic-based therapeutic products.
When was Propeller Bio founded?
Propeller Bio was founded in -1.
Where is Propeller Bio based?
Propeller Bio is headquartered in Redwood City, United States, in the North America region.
Who are Propeller Bio's main competitors?
Direct peers on record are Crinetics Pharmaceuticals, CytomX Therapeutics, Surrozen, Werewolf Therapeutics, Adagene, AbCellera Biologics, Generate Biomedicines and Atreca. Broad incumbents are BioMarin Pharmaceutical and Ginkgo Bioworks.
Does Propeller Bio have an API?
No public API is recorded for Propeller Bio.
What industry is Propeller Bio in?
Propeller Bio's product category is Biologic Therapeutics. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 325414 and its SIC code is 8731.